Print  |  Close

Emory University School of Medicine

Treatment Sites in Georgia

Clinical Trials in Georgia

A Multicenter, Open Label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial
Cancer Type: Unknown Primary

A Phase 1 Multiple Ascending Dose Study of DS-3201b in Subjects With Lymphomas
Cancer Type: Leukemia, Lymphoma, Non-Hodgkin Lymphoma

A Phase 1 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors, Including RET-Fusion Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, and Other Tumors With Increased RET Activity
Cancer Type: Colon/Rectal Cancer, Lung Cancer, Skin Cancer (Non-Melanoma), Thyroid Cancer, Unknown Primary

A Phase 2, Multicohort, Open-label, Multicenter Study to Determine the Efficacy and Safety of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma Having Progressed Within One Year of Initial Treatment (KarMMa-2)
Cancer Type: Lymphoma, Multiple Myeloma

A Phase III Multicenter, Open Label Randomized Controlled Trial of Cefoxitin versus Piperacillin-Tazobactam as Surgical Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy
Cancer Type: Unspecified

A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Cancer Type: Ovarian Cancer

GRAVITAS-119: A Single-Arm, Open-Label, Phase 1 Study of Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Cancer Type: Leukemia, Lymphoma, Myelodysplastic Syndromes (MDS)

ONC201 in Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Recurrent / Refractory Pediatric H3 K27M Gliomas
Cancer Type: Brain Cancer

Phase Ib Study of Tisagenlecleucel in Combination With Pembrolizumab in Relapsed / Refractory (r / r) Diffuse Large B-cell Lymphoma (DLBCL) Patients.
Cancer Type: Lymphoma

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes
Cancer Type: Unspecified
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.